Till Örebro universitet

oru.seÖrebro universitets publikationer
EnglishSvenskaNorsk
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
2025 European guideline on the management of Chlamydia trachomatis infections
Northern and Western Health & Social Care Trusts, Londonderry, UK.
Department of Health Promotion, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; Department of Sexual Health, Infectious Diseases and Environmental Health, Living Lab. Public Health Mosa, South Limburg Public Health Service, Heerlen, the Netherlands.
Department of Sexual Health, Infectious Diseases and Environmental Health, Living Lab. Public Health Mosa, South Limburg Public Health Service, Heerlen, the Netherlands; Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; Department of Medical Microbiology, Infectious Diseases and Infection Prevention, Dutch National Chlamydia trachomatis Reference Laboratory, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.
Institute of Tropical Medicine, Antwerp, Belgium.
Visa övriga samt affilieringar
2025 (Engelska)Ingår i: International Journal of STD and AIDS (London), ISSN 0956-4624, E-ISSN 1758-1052, artikel-id 9564624251323678Artikel i tidskrift (Refereegranskat) Epub ahead of print
Abstract [en]

Sexually transmitted Chlamydia trachomatis infections remain common globally and most frequently are asymptomatic. The 2025 European C. trachomatis guideline provides up-to-date guidance regarding indications for testing and treatment of C. trachomatis infections. It includes advice on urogenital and extragenital C. trachomatis testing including the use of self-collected specimens; recommendation to use only validated NAATs for diagnosis; and recommendation to treat all C. trachomatis infections with doxycycline as first line in preference to single-dose azithromycin regimens. The absence of evidence and limited value of broad screening in asymptomatic populations for C. trachomatis infections is also discussed.
Ort, förlag, år, upplaga, sidor
Royal Society of Medicine Press, 2025. artikel-id 9564624251323678
Nyckelord [en]
Chlamydia trachomatis, Europe, antibiotic, diagnosis, treatment
Nationell ämneskategori
Infektionsmedicin
Identifikatorer
URN: urn:nbn:se:oru:diva-119666DOI: 10.1177/09564624251323678ISI: 001436493600001PubMedID: 40037375OAI: oai:DiVA.org:oru-119666DiVA, id: diva2:1942604
Tillgänglig från: 2025-03-05 Skapad: 2025-03-05 Senast uppdaterad: 2025-03-17Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed

Person

Unemo, Magnus

Sök vidare i DiVA

Av författaren/redaktören
Unemo, Magnus
Av organisationen
Institutionen för medicinska vetenskaperRegion Örebro län
I samma tidskrift
International Journal of STD and AIDS (London)
Infektionsmedicin

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 45 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
v. 2.46.0
|
WCAG
|
Örebro universitetsbibliotek
|
DiVA Portal
|
DiVA Logga in
|
Registrering i DiVA
|
Kontakta oss